http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009221219-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5bcd4986b341cf8b84e060483471051
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-13
filingDate 2009-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aee6a9b2850374c7e56cb92973b89a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c8c72a57166d74c27150262502d89b5
publicationDate 2009-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009221219-A
titleOfInvention Substituted tetracycline compounds for the treatment of malaria
abstract A method for treating or preventing malaria in a subject is provided. A method of treating or preventing malaria, wherein an effective amount of a substituted tetracycline compound is administered to a subject. The tetracycline compound is a compound represented by Formula I. Wherein X is CR6′R6, O, etc., R2, R2 ′, R4 ′, and R4 ″ are individually hydrogen, etc., R4 is NR4′R4 ″, etc., and R3, R11, And R12 are each hydrogen or the like, R10 is hydrogen or the like or is bonded to R9 to form a ring, R5 is hydroxyl or the like, and R6 and R6 ′ are each independently hydrogen R7 is a malaria interaction part or the like, R9 is a malaria interaction part or the like, and R13 is hydrogen or the like. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008266330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010090138-A
priorityDate 2001-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6043231-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9937306-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0028983-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9808480-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0064479-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9930720-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776

Total number of triples: 42.